Skip to content
★ Sign in to follow
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€185k

Latest filing published 03 May 2023 for Veradigm Inc., €78k.

Filing timeline

BuySale
Leah Jones

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Leah Jones: trading record in brief

Leah Jones discloses dealings in Veradigm Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 15 August 2022 to 2 May 2023.

Sales make up the whole of the open-market record (3 sales, €185k). Other entries cover 4 share grants.

Most recently, on 3 May 2023, the filings show a share grant worth €25k in Veradigm Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Leah Jones

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    Chief Financial OfficerExecutivesVeradigm Inc.
    86,031 USD25SEC
    6,866 shares@ US$12.5359.4% of flowCommon StockSEC:0001209191-23-026968:0
  • ◆
    Chief Financial OfficerExecutivesVeradigm Inc.
    58,373 USD23SEC
    4,473 shares@ US$13.0540.6% of flowCommon StockSEC:0001209191-23-022382:0
  • ▼
    Chief Financial OfficerExecutivesAllscripts Healthcare Solutions, Inc.
    116,331 USD39SEC
    7,000 shares@ US$16.618799.6% of flowCommon StockSEC:0001209191-22-049927:0
  • ▼
    Chief Financial OfficerExecutivesAllscripts Healthcare Solutions, Inc.
    424 USD31SEC
    24 shares@ US$17.650.4% of flowCommon StockSEC:0001209191-22-046729:0

4 of 4 declarations